Axcelis Technologies, Inc. (FRA:XXA1)
| Market Cap | 3.32B +52.4% |
| Revenue (ttm) | 758.07M -3.4% |
| Net Income | 81.22M -41.5% |
| EPS | 2.61 -39.2% |
| Shares Out | n/a |
| PE Ratio | 40.86 |
| Forward PE | 26.08 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 105.25 |
| Previous Close | 104.10 |
| Day's Range | 105.25 - 105.25 |
| 52-Week Range | 63.28 - 162.05 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 6, 2026 |
About Axcelis Technologies
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific. The company provides high energy, high current, and medium current implanters for various application requirements. It also offers aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. The company sells its equipment and services to semiconductor ch... [Read more]
Financial Performance
In 2025, Axcelis Technologies's revenue was $839.05 million, a decrease of -17.57% compared to the previous year's $1.02 billion. Earnings were $120.24 million, a decrease of -40.18%.
Financial numbers in USD Financial StatementsNews
Axcelis price target raised to $198 from $180 at B. Riley
B. Riley analyst Craig Ellis raised the firm’s price target on Axcelis (ACLS) to $198 from $180 and keeps a Buy rating on the shares. The company’s Q2 report and…
Axcelis downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Christian Schwab downgraded Axcelis (ACLS) to Hold from Buy with a price target of $140, down from $173. The company reported a Q2 beat but its revenue outlook…
Axcelis Technologies Earnings Call Transcript: Q2 2026
Q2 2026 revenue and EPS exceeded expectations, driven by strong execution and demand in power, memory, and CS&I segments. Full-year revenue growth is now projected at mid-single digits, with continued momentum into 2027 and progress on the Veeco merger.
Axcelis Technologies Earnings release: Q2 2026
Axcelis Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Axcelis Technologies Slides: Q2 2026
Axcelis Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Axcelis Technologies Quarterly report: Q2 2026
Axcelis Technologies has published its Q2 2026 quarterly earnings report on August 6, 2026.
Axcelis Announces Financial Results for Second Quarter 2026
Q2 2026 Highlights: Revenue of $215.2 million GAAP Gross Margin of 42.4%, and Non-GAAP Gross Margin of 42.7% GAAP Operating Margin of 9.4% and Non-GAAP Operating Margin of 14.7% GAAP Diluted Earnings ...
Axcelis Announces Participation in Upcoming Investor Conferences in August
BEVERLY, Mass., July 29, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company...
Axcelis Announces Successful Purion XEmax Eval Closure at Leading Semiconductor Foundry
System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability BEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading su...
Axcelis Announces Timing and Availability of Second Quarter 2026 Results and Conference Call
BEVERLY, Mass., July 22, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial...
Axcelis price target raised to $156 from $130 at BofA
BofA raised the firm’s price target on Axcelis (ACLS) to $156 from $130 and keeps an Underperform rating on the shares. The firm updated its semis industry models and price…
Axcelis Announces Participation in Upcoming Investor Conferences
BEVERLY, Mass., May 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company'...
Axcelis price target raised to $180 from $150 at B. Riley
B. Riley raised the firm’s price target on Axcelis (ACLS) to $180 from $150 and keeps a Buy rating on the shares. The firm updated the company’s model following the…
Axcelis Technologies Earnings Call Transcript: Q1 2026
Q1 2026 revenue and EPS slightly exceeded expectations despite a one-time settlement. Memory and silicon carbide segments showed strong growth, while general mature remained soft but showed rising utilization. Full-year revenue is expected to be flat, with momentum building for 2027.
Axcelis Technologies Earnings release: Q1 2026
Axcelis Technologies released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Axcelis Technologies Slides: Q1 2026
Axcelis Technologies has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
Axcelis Technologies Quarterly report: Q1 2026
Axcelis Technologies has published its Q1 2026 quarterly earnings report on May 7, 2026.
Axcelis Announces Financial Results for First Quarter 2026
Q1 2026 Highlights: Revenue of $199.0 million GAAP Gross Margin of 40.5%, and Non-GAAP Gross Margin of 40.7% GAAP Operating Margin of 4.0% and Non-GAAP Operating Margin of 11.7% GAAP Diluted Earnings ...
Axcelis to Participate in ASMC 2026
BEVERLY, Mass., May 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today it will...
Axcelis Announces Timing and Availability of First Quarter 2026 Results and Conference Call
BEVERLY, Mass., April 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financia...
Axcelis upgraded to Buy from Neutral at B. Riley
B. Riley analyst Craig Ellis upgraded Axcelis (ACLS) to Buy from Neutral with a price target of $150, up from $91. The firm expects better results for Q1 vs. consensus…
Axcelis upgraded to Buy from Neutral at B. Riley
B. Riley analyst Craig Ellis upgraded Axcelis (ACLS) to Buy from Neutral with a $150 price target
Axcelis Technologies Proxy statement: Proxy filing
Axcelis Technologies filed a proxy statement on March 31, 2026, providing details for shareholder voting and corporate governance matters.
